Medical News

RSS

Synovis Life Technologies' second-quarter 2010 net revenue up 19%

Synovis Life Technologies, Inc., today reported record revenue for the second quarter ended April 30, 2010.

26 May 2010

Anadys Pharmaceuticals to raise $12.5 million through registered direct offering

Anadys Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with certain institutional investors to raise approximately $12.5 million in gross proceeds in a "registered direct" offering through the sale of a total of 5,813,954 shares of its common stock at an offering price of $2.15 per share. Anadys estimates that net proceeds from the offering will be approximately $11.3 million, after deducting placement agents' fees and estimated offering expenses.

26 May 2010

Investment banker with Brachial Plexus Palsy climbs all Seven Summits

Paul Fejtek has successfully achieved his goal of being the first person with Brachial Plexus Palsy to climb all Seven Summits (the highest mountain on each continent). With wife Denise by his side, Paul reached the earth's highest peak and paused for a moment to take it all in. "Standing on the summit of Mt. Everest was truly amazing," he said. "It was the experience of a lifetime."

26 May 2010

Study looks at firearm-related mortality among children and adolescents in the U.S.

Children in the U.S. are just as likely to die from gunshot wounds if they live in the largest cities or the smallest towns. However, teens living in the most urban counties are more likely to die from gun violence, while children in the most remote areas of the country are more likely to die in gun-related accidents or suicides, according to new research by The Children's Hospital of Philadelphia.

26 May 2010

Lymphoma Foundation Canada applauds Ontario government's decision to publicly fund Rituxan for CLL

Lymphoma Foundation Canada (LFC) applauds Ontario's recent decision to publicly fund Rituxan (rituximab) in combination with Fludarabine-based chemotherapy for patients with previously untreated chronic lymphocytic leukemia (CLL).

26 May 2010

Research findings offer possible applications in diagnosis and treatment of patients with atherosclerosis

Researchers from Boston University School of Medicine have shown that use of magnetic resonance imaging in an animal model can non-invasively identify dangerous plaques. The findings, which appear in the May issue of Circulation Cardiovascular Imaging, offer possible applications in the diagnosis and treatment of patients with atherosclerosis.

26 May 2010

St. Jude Medical to evaluate cost-effectiveness of FFR for multivessel coronary artery disease

St. Jude Medical, Inc., a global medical device company, announced today at EuroPCR it will evaluate the incremental cost-effectiveness of Fractional Flow Reserve (FFR)-guided treatment for patients with multivessel coronary artery disease in the UK, Germany, France, Italy, Switzerland, Belgium and Canada. The analysis will also determine FFR's potential health and budget impact for each of the seven countries.

26 May 2010

New book summarizes current state of research on NF-κB

NF-κB is a critical signaling molecule in the immune system that regulates cell survival and cell death, lymphocyte responses, and inflammation. Acting as a transcription factor that can receive several inputs, it coordinates distinct gene expression programs in response to a wide variety of stimuli.

26 May 2010

TASE approves new listing of PROLOR Biotech's common stock

PROLOR Biotech, Inc.,, a company developing next generation biobetter therapeutic proteins, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of PROLOR's common stock on the TASE beginning on Thursday, May 27, 2010. At that time, the company's common stock will be listed on both the NYSE Amex in the United States and the TASE in Israel.

26 May 2010

EMEND indication helps women prevent CINV

More women fighting cancers such as breast, lung, colorectal and ovarian can now help prevent the nausea and vomiting associated with their treatment of moderately emetogenic (vomit-inducing) cancer chemotherapy. Although new treatment entities have been developed in the past 10 years for control of chemically-induced nausea and vomiting, CINV remains a significant problem in the context of current practice.

26 May 2010

CTRC starts enrolment in Phase 2 combination trial of REOLYSIN and gemcitabine for advanced pancreatic cancer

Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.

26 May 2010

Humana named nation's top payer for the second consecutive

For the second year in a row and third time in five years, Humana Inc. ranks #1 in overall performance - making it the easiest payer for health care providers to do business with - in a review of 2009 claims-payment data conducted by athenahealth Inc., a provider of Internet-based business services to doctors, and Physician's Practice magazine.

26 May 2010

Perrigo acquires rights to ANDA for HalfLytely and Bisacodyl Tablets Bowel Prep Kit

Perrigo Company today announced that it has acquired rights to Novel Laboratories' pending ANDA for HalfLytely and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets), indicated for the cleansing of the colon as a preparation for colonoscopy in adults.

26 May 2010

VisEn Medical announces launch of two new imaging agents at EMIM 2010

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the commercial launch of two new imaging agents -- ProSense® 750 FAST for expanded versatility in imaging cathepsin activity, and Neutrophil Elastase™ 680 FAST, for imaging of inflammatory elastase activity associated with disease progression and therapeutic response. The launch announcements were made at the European Molecular Imaging Meeting (EMIM) 2010 in Warsaw, Poland.

26 May 2010

FDA approves Mylan's ANDA for Valacyclovir Hydrochloride Tablets

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Valacyclovir Hydrochloride Tablets, 500 mg (base) and 1000 mg (base), the generic version of GlaxoSmithKline's Valtrex, a treatment for the herpes virus infection.

26 May 2010

Jubilant Organosys announces repayment of FCCBs amounting to $50M and YTM of $19M

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company out of India, today announced the repayment of FCCBs amounting to US$ 50 million along with the YTM of US$ 19 million. The FCCBs were due for redemption on May 24, 2010.

26 May 2010

National Council on Skin Cancer Prevention introduces Don't Fry Day to encourage sun safety awareness

As millions of Americans prepare to enjoy the great outdoors Memorial Day weekend, the National Council on Skin Cancer Prevention reminds everyone to practice sun-safe behaviors – pack those wide-brimmed hats in the suitcase. The incidence of melanoma (the most fatal of skin cancers) continues to rise significantly, at a rate faster than any of the seven most common cancers.

26 May 2010

Gentium first-quarter net loss decreases to EUR 0.03 million

Gentium S.p.A. today reported financial results for the quarter ended March 31, 2010. The Company reports its financial condition and operating results using U.S. Generally Accepted Accounting Principles (GAAP).

26 May 2010

IPC The Hospitalist Company acquires Continuum Geriatric Services

IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has acquired Continuum Geriatric Services PLLC (CGS), headquartered in Livonia, Michigan. CGS practices in more than 60 nursing and assisted living facilities in Michigan, where IPC has an established presence. CGS has an annualized volume of approximately 105,000 patient encounters.

26 May 2010

First Edition: May 26, 2010

Today's headlines detail the latest developments regarding legislation moving through Congress that would prevent scheduled cuts in Medicare physician payment and extend health insurance subsidies for unemployed people.

26 May 2010

Medical News

Synovis Life Technologies' second-quarter 2010 net revenue up 19%

Anadys Pharmaceuticals to raise $12.5 million through registered direct offering

Investment banker with Brachial Plexus Palsy climbs all Seven Summits

Study looks at firearm-related mortality among children and adolescents in the U.S.

Lymphoma Foundation Canada applauds Ontario government's decision to publicly fund Rituxan for CLL

Research findings offer possible applications in diagnosis and treatment of patients with atherosclerosis

St. Jude Medical to evaluate cost-effectiveness of FFR for multivessel coronary artery disease

New book summarizes current state of research on NF-κB

TASE approves new listing of PROLOR Biotech's common stock

EMEND indication helps women prevent CINV

CTRC starts enrolment in Phase 2 combination trial of REOLYSIN and gemcitabine for advanced pancreatic cancer

Humana named nation's top payer for the second consecutive

Perrigo acquires rights to ANDA for HalfLytely and Bisacodyl Tablets Bowel Prep Kit

VisEn Medical announces launch of two new imaging agents at EMIM 2010

FDA approves Mylan's ANDA for Valacyclovir Hydrochloride Tablets

Jubilant Organosys announces repayment of FCCBs amounting to $50M and YTM of $19M

National Council on Skin Cancer Prevention introduces Don't Fry Day to encourage sun safety awareness

Gentium first-quarter net loss decreases to EUR 0.03 million

IPC The Hospitalist Company acquires Continuum Geriatric Services

First Edition: May 26, 2010

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News